Open original FDA record ↗Recall record
- FDA identifier
- Z-0765-06
- Company in FDA record
- Ortho-Clinical Diagnostics
- FDA classification date
- Apr 20, 2006
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Firm received complaints of biased results when using VITROS Signal Reagent, Lots 8350 and 8530. VITROS Signal Reagent is used with the VITROS Immunodiagnostic ECi/ECiQ laboratory system, and when used may produce inaccurate test results in some cases.
Source facts
- Action
- Ortho-Clinical Diagnostics sent "Urgent Product Correction/Recall Notification" letters, dated 3/28/06, to the customers via overnight mail. Ortho-Clinical Diagnostics issued a nationwide press release on 3/31/06. Patients who have had diagnostic testing performed for any of these medical conditions within the last 60 days and are concerned with their test results are recommended to discuss this matter with their physicians. Ortho-Clinical Diagnostics has advised laboratories, using this reagent, to contact the patient's physician if there are any concerns regarding previous test results. Customers with questions may contact the company at 1-800-421-3311. Additionally, Ortho-Clinical Diagnostics notified all end users of the VITROS ECi/ECiQ Immunodiagnostic System in the US and globally.
- Initiated
- 2006-03-28
- Root cause
- Other
- Terminated
- 2007-12-14
- Distribution
- Medical facilities nationwide and 1 foreign affiliate in Canada.
- Recall number
- Z-0765-06
- Recall status
- Terminated
- CDRH record ID
- 45148
- FDA classified
- 2006-04-20
- Recall event number
- 35020